The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

It all started with a brain, an athlete, a basket case, a princess and a criminal. In 1985, the world was introduced to five ...

Michael Kennedy: "We've really hit an amazing stride in terms of basket innovation, and we've really embraced some new technology to help us do that." ...

CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.

The University of Massachusetts at Amherst student thought he won a basketball shooting contest, but his foot on the line ...

Blackburn Rovers’ fall from grace in recent years has been driven by the incompetence of owners who don’t care about the club ...

In a presentation, AFS Group research director Arne Petimezas argued the U.K. is not the basket case that many investors make it out to be. While the country's economic growth has been slow, it is in ...

Additional gains in endurance time and reductions in symptoms of dyspnoea were observed during an endurance cycling test (secondary outcome) Trial registration number NCT01397396; Results.

2 Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands 3 Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands ...

Design Single centre randomised controlled trial. Setting Level III neonatal intensive care unit at the Coombe Women and Infants University Hospital, Dublin, Ireland. Patients Very low birthweight ...

The Phase 1 RESOLUTION basket trial will evaluate the safety and preliminary efficacy of ALLO-329 in patients with systemic lupus erythematosus, including lupus nephritis, idiopathic inflammatory ...